Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure
Article first published online: 9 JUL 2004
Clinical & Experimental Allergy
Volume 34, Issue 7, pages 1056–1063, July 2004
How to Cite
Von Bubnoff, D., Fimmers, R., Bogdanow, M., Matz, H., Koch, S. and Bieber, T. (2004), Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clinical & Experimental Allergy, 34: 1056–1063. doi: 10.1111/j.1365-2222.2004.01984.x
- Issue published online: 9 JUL 2004
- Article first published online: 9 JUL 2004
- Submitted 28 November 2003; revised 10 March 2004; accepted 1 April 2004
- allergic rhinitis;
- clinical manifestation;
- tryptophan degradation
Background Indoleamine 2,3-dioxygenase (IDO) is a tryptophan (TRP)-catabolizing enzyme with regulatory effects on T cells. T cell inhibition is achieved through both TRP depletion and TRP metabolite accumulation in specific local tissue microenvironments. The expression of IDO activity by different types of antigen-presenting cells (APCs) has been shown to play a role in many instances of immunoregulation and tolerance induction. Induction of IDO after the engagement of the high-affinity receptor for IgE, FcɛRI, on atopic monocytes has been suggested to regulate T cell responses in atopic disorders. Interleukin-10 (IL-10), a cytokine known for its down-regulatory functions in the immune system, has recently been associated with the stable expression of IDO in mature tolerogenic dendritic cells.
Objective This study was devised to understand the role of systemic IDO and IL-10 in the prevention of clinical apparent allergy.
Methods The concentration of TRP and the break-down product kynurenine were measured by high-performance liquid chromatography in- and off-season in sera from patients with seasonal allergic rhinitis (n=12) and from clinically asymptomatic atopic patients sensitized to specific aeroallergens (n=12). Non-atopic (NA) individuals (n=12) served as control. The concentration of plasma IL-10 was determined in parallel from these donors by ELISA in- and off-season.
Results In clinically unresponsive but aeroallergen-sensitized atopic individuals significantly higher systemic activity of IDO and increased plasma IL-10 levels were found during allergen exposure but not off-season compared to symptomatic atopic individuals with allergic rhinitis and NA individuals.
Conclusion Enhanced systemic IDO activity as well as increased systemic levels of IL-10 may contribute to the containment of allergic T cell responses and could be involved in the maintenance of a state of clinical unresponsiveness.